Campath and graft versus host disease 
Campath and graft versus host disease Patient Reports February 10, 2010
Campath Side Effects Report #5534400-3
Campath side effect was reported by a Physician from UNITED STATES on Nov 19, 2007. Male patient, 75 years of age, was diagnosed with chronic lymphocytic leukaemia and was treated with Campath. After drug was administered, patient experienced the following side effects: cytomegalovirus infection
, graft versus host disease, sepsis . Campath dosage: unknown. Patient died on 11/01/2007.Campath Side Effects Report #5557415-8
Campath side effect was reported by a Physician from UNITED STATES on Nov 19, 2007. Male patient, 75 years of age, was diagnosed with chronic lymphocytic leukaemia and was treated with Campath. After drug was administered, patient experienced the following side effects: cytomegalovirus infection
, graft versus host disease, sepsis . Campath dosage: unknown. Patient died on 11/01/2007.Campath Side Effects Report #5570797-6
Campath side effect was reported by a Physician from UNITED STATES on Dec 12, 2007. Male patient, 75 years of age, was diagnosed with chronic lymphocytic leukaemia and was treated with Campath. After drug was administered, patient experienced the following side effects: abdominal distension, abdominal pain
, cytomegalovirus infection , diarrhoea, dyspnoea, graft versus host disease, hypotension, liver function test abnormal, nausea . Campath dosage: unknown. During the same period patient was treated with FLUDARABINE PHOSPHATE, RITUXIMAB. Patient was hospitalized. Patient died on 11/14/2007.Campath Side Effects Report #5574238-4
Campath side effect was reported by a Physician from UNITED STATES on Dec 12, 2007. Male patient, 75 years of age, was diagnosed with chronic lymphocytic leukaemia and was treated with Campath. After drug was administered, patient experienced the following side effects: abdominal distension, abdominal pain
, cytomegalovirus infection , diarrhoea, dyspnoea, graft versus host disease, hypotension, liver function test abnormal, nausea . Campath dosage: unknown. During the same period patient was treated with FLUDARABINE PHOSPHATE, RITUXIMAB. Patient was hospitalized. Patient died on 11/14/2007.Campath Side Effects Report #5582879-3
Campath side effect was reported by a Health Professional from UNITED STATES on Dec 28, 2007. Male patient, 75 years of age, weighting 235.9 lb, was diagnosed with chronic lymphocytic leukaemia and was treated with Campath. After drug was administered, patient experienced the following side effects: abdominal distension, abdominal pain
, cytomegalovirus infection , diarrhoea, dyspnoea, graft versus host disease, hypotension, liver function test abnormal, multi-organ failure. Campath dosage: unknown. During the same period patient was treated with FLUDARABINE PHOSPHATE, RITUXIMAB. Patient was hospitalized. Patient died on 11/17/2007.Campath Side Effects Report #5592776-5
Campath side effect was reported by a Health Professional from UNITED STATES on Dec 28, 2007. Male patient, 75 years of age, weighting 235.9 lb, was diagnosed with chronic lymphocytic leukaemia and was treated with Campath. After drug was administered, patient experienced the following side effects: abdominal distension, abdominal pain
, cytomegalovirus infection , diarrhoea, dyspnoea, graft versus host disease, hypotension, liver function test abnormal, multi-organ failure. Campath dosage: unknown. During the same period patient was treated with FLUDARABINE PHOSPHATE, RITUXIMAB. Patient was hospitalized. Patient died on 11/17/2007.Campath Side Effects Report #5643393-X
Campath side effect was reported by a Health Professional from UNITED STATES on Feb 20, 2008. Male patient, 75 years of age, weighting 235.9 lb, was diagnosed with chronic lymphocytic leukaemia and was treated with Campath. After drug was administered, patient experienced the following side effects: abdominal distension, abdominal pain
, cytomegalovirus infection , diarrhoea, dyspnoea, graft versus host disease, hypotension, liver function test abnormal, multi-organ failure. Campath dosage: unknown. During the same period patient was treated with FLUDARABINE, RITUXIMAB. Patient was hospitalized. Patient died on 11/17/2007.Campath Side Effects Report #5648298-6
Campath side effect was reported by a Health Professional from UNITED STATES on Feb 20, 2008. Male patient, 75 years of age, weighting 235.9 lb, was diagnosed with chronic lymphocytic leukaemia and was treated with Campath. After drug was administered, patient experienced the following side effects: abdominal distension, abdominal pain
, cytomegalovirus infection , diarrhoea, dyspnoea, graft versus host disease, hypotension, liver function test abnormal, multi-organ failure. Campath dosage: unknown. During the same period patient was treated with FLUDARABINE, RITUXIMAB. Patient was hospitalized. Patient died on 11/17/2007.Campath Side Effects Report #5747418-2
Campath side effect was reported by a Health Professional from UNITED STATES on May 20, 2008. Male patient, 75 years of age, weighting 235.9 lb, was diagnosed with chronic lymphocytic leukaemia and was treated with Campath. After drug was administered, patient experienced the following side effects: abdominal distension, abdominal pain
, cytomegalovirus infection , diarrhoea, dyspnoea, graft versus host disease, hypotension, liver function test abnormal, multi-organ failure. Campath dosage: unknown. During the same period patient was treated with FLUDARABINE PHOSPHATE, RITUXIMAB. Patient was hospitalized. Patient died on 11/17/2007.Campath Side Effects Report #5755329-1
Campath side effect was reported by a Health Professional from UNITED STATES on May 07, 2008. Male patient, 75 years of age, weighting 235.9 lb, was diagnosed with chronic lymphocytic leukaemia and was treated with Campath. After drug was administered, patient experienced the following side effects: abdominal distension, abdominal pain
, cytomegalovirus infection , diarrhoea, dyspnoea, graft versus host disease, hypotension, liver function test abnormal, multi-organ failure. Campath dosage: unknown. During the same period patient was treated with FLUDARABINE PHOSPHATE, RITUXIMAB. Patient was hospitalized. Patient died on 11/17/2007.Campath Side Effects Report #5796257-5
Campath side effect was reported by a Health Professional from UNITED STATES on June 25, 2008. Male patient, 75 years of age, weighting 235.9 lb, was diagnosed with chronic lymphocytic leukaemia and was treated with Campath. After drug was administered, patient experienced the following side effects: abdominal distension, abdominal pain
, constipation , cytomegalovirus infection , diarrhoea, dyspnoea, graft versus host disease, hypotension, lipase increased. Campath dosage: unknown. During the same period patient was treated with FLUDARABINE PHOSPHATE, RITUXIMAB. Patient was hospitalized. Patient died on 11/17/2007.Campath Side Effects Report #5809547-4
Campath side effect was reported by a Health Professional from UNITED STATES on July 07, 2008. Male patient, 75 years of age, weighting 235.9 lb, was diagnosed with chronic lymphocytic leukaemia and was treated with Campath. After drug was administered, patient experienced the following side effects: abdominal distension, abdominal pain
, constipation , cytomegalovirus infection , diarrhoea, dyspnoea, graft versus host disease, hypotension, lipase increased. Campath dosage: unknown. During the same period patient was treated with FLUDARABINE PHOSPHATE, RITUXIMAB. Patient was hospitalized. Patient died on 11/17/2007.Campath Side Effects Report #5811474-3
Campath side effect was reported by a Health Professional from UNITED STATES on July 07, 2008. Male patient, 75 years of age, weighting 235.9 lb, was diagnosed with chronic lymphocytic leukaemia and was treated with Campath. After drug was administered, patient experienced the following side effects: abdominal distension, abdominal pain
, constipation , cytomegalovirus infection , diarrhoea, dyspnoea, graft versus host disease, hypotension, lipase increased. Campath dosage: unknown. During the same period patient was treated with FLUDARABINE PHOSPHATE, RITUXIMAB. Patient was hospitalized. Patient died on 11/17/2007.Campath Side Effects Report #5030900-3
Campath side effect was reported by a Physician from GERMANY on June 12, 2006. Male patient, 64 years of age, was diagnosed with chronic lymphocytic leukaemia and was treated with Campath. After drug was administered, patient experienced the following side effects: graft versus host disease, graft versus host disease in skin, pancytopenia, pneumonia
. Campath dosage: unknown. During the same period patient was treated with CYCLOPHOSPHAMIDE, FLUDARABINE PHOSPHATE, DEXAMETHASONE, CARMUSTINE, ETOPOSIDE, CYTARABINE, MELPHALAN. Patient died.Campath Side Effects Report #5043113-6
Campath side effect was reported by a Physician from GERMANY on June 12, 2006. Male patient, 54 years of age, was diagnosed with chronic lymphocytic leukaemia and was treated with Campath. After drug was administered, patient experienced the following side effects: cholestasis, graft versus host disease, thrombocytopenia. Campath dosage: 3/10/30MG; SEE IMAGE. During the same period patient was treated with CYCLOPHOSPHAMIDE. Patient recovered.
Campath Side Effects Report #5030496-6
Campath side effect was reported by a Physician from GERMANY on June 01, 2006. Female patient, 52 years of age, was diagnosed with chronic lymphocytic leukaemia and was treated with Campath. After drug was administered, patient experienced the following side effects: dermatitis exfoliative, graft versus host disease, human herpes virus 6 serology positive, pancytopenia, sicca syndrome. Campath dosage: unknown. During the same period patient was treated with CYCLOPHOSPHAMIDE. Patient recovered.
Campath Side Effects Report #5043110-0
Campath side effect was reported by a Physician from GERMANY on June 12, 2006. Female patient, 52 years of age, was diagnosed with chronic lymphocytic leukaemia and was treated with Campath. After drug was administered, patient experienced the following side effects: dermatitis exfoliative, graft versus host disease, human herpes virus 6 serology, pancytopenia, sicca syndrome. Campath dosage: 3/10/30MG; SEE IMAGE. During the same period patient was treated with CYCLOPHOSPHAMIDE. Patient recovered.
Campath Side Effects Report #5030894-0
Campath side effect was reported by a Physician from GERMANY on June 12, 2006. Male patient, 34 years of age, was diagnosed with chronic lymphocytic leukaemia and was treated with Campath. After drug was administered, patient experienced the following side effects: cholestasis, conjunctivitis, dry skin, graft versus host disease, herpes zoster, pancytopenia, pruritus. Campath dosage: unknown. During the same period patient was treated with CYCLOPHOSPHAMIDE. Patient recovered.
Campath Side Effects Report #5030506-6
Campath side effect was reported by a Physician from GERMANY on June 01, 2006. Male patient, 54 years of age, was treated with Campath. After drug was administered, patient experienced the following side effects: cholestasis, dermatitis exfoliative, graft versus host disease, rash maculo-papular, thrombocytopenia. Campath dosage: unknown. During the same period patient was treated with CYCLOPHOSPHAMIDE. Patient recovered.
Campath Side Effects Report #5030923-4
Campath side effect was reported by a Physician from GERMANY on June 12, 2006. Female patient, 53 years of age, was treated with Campath. After drug was administered, patient experienced the following side effects: cytomegalovirus infection
, graft versus host disease, herpes zoster. Campath dosage: 3/10/30 MG, INTRAVENOUS; 30 MG, INTRAVENOUS. During the same period patient was treated with CYCLOPHOSPHAMIDE. Patient recovered.Campath Side Effects Report #5030485-1
Campath side effect was reported by a Physician from GERMANY on June 01, 2006. Male patient, 51 years of age, was treated with Campath. After drug was administered, patient experienced the following side effects: autoimmune thyroiditis, cholestasis, conjunctivitis, diarrhoea, eczema
, erythema, graft versus host disease, herpes zoster, pneumonitis. Campath dosage: unknown. During the same period patient was treated with CYCLOPHOSPHAMIDE. Patient recovered.Campath Side Effects Report #5030487-5
Campath side effect was reported by a Physician from GERMANY on June 01, 2006. Female patient, 51 years of age, was treated with Campath. After drug was administered, patient experienced the following side effects: cholestasis, chronic lymphocytic leukaemia transformation, conjunctivitis, eczema
, erythema, graft versus host disease, sicca syndrome, stem cell transplant. Campath dosage: unknown. During the same period patient was treated with CYCLOPHOSPHAMIDE. Patient recovered.Campath Side Effects Report #5041375-2
Campath side effect was reported by a Physician from GERMANY on June 12, 2006. Female patient, 51 years of age, was treated with Campath. After drug was administered, patient experienced the following side effects: cholestasis, chronic lymphocytic leukaemia transformation, conjunctivitis, eczema
, erythema, graft versus host disease, sicca syndrome. Campath dosage: 3/10/30MG, INTRAVENOUS; 30 MG,. During the same period patient was treated with CYCLOPHOSPHAMIDE. Patient recovered.